COMMUNIQUÉS West-GlobeNewswire

Össur hf: Q2 Results 2017

25/07/2017 - 22:00

Announcement no. 52/2017 Interim report for the first six months of 2017 25 July 2017 Össur Q2 2017 highlights Sales amounted to USD 145 million compared to USD 139 million in Q2 2016, corresponding to 6% growth and 3% [...]

Medasys - Son expansion internationale soulignée par l'étude de marché KLAS

25/07/2017 - 18:38

Etude de renommée internationale, l'analyse menée par l'institut de recherche américain KLAS, porte sur l'acquisition et le déploiement des dossiers patients informatisés (DPI) à l'échelle mondiale (hors Etats-Unis). [...]

Corning and Stevanato Group Enter New Agreement to Supply New Corning Valor(TM) Glass to the Pharmaceutical Packaging Market

25/07/2017 - 18:21

Remarkable glass innovation enables enhanced quality parenteral packaging CORNING, N.Y., and PIOMBINO, DESE, PADUA, Italy; JULY 25, 2017 - Corning Incorporated (NYSE: GLW) and Stevanato Group announced today a new [...]

Oriola Corporation - Repurchase of own shares on 25 July 2017

25/07/2017 - 17:46

ORIOLA CORPORATION STOCK EXCHANGE RELEASE 25 JULY 2017 AT 18:45 EEST In the Nasdaq Helsinki Date 25 July 2017 Exchange transaction Buy Share trading code OKDBV Amount, shares 13,485 Average price/share, EUR 3,5553 Total [...]

RedHill Biopharma Reports 2017 Second Quarter Financial Results

25/07/2017 - 13:20

RedHill maintains a debt-free balance sheet with $51 million cash 1 at the end of the second quarter of 2017 Select recent milestones include: Initial net revenues of approximately $0.5 million between June 12-30 [...]

Virbac : bilan semestriel contrat de liquidité au 30 juin 2017

25/07/2017 - 11:42

Carros, le 5 juillet 2017 BILAN SEMESTRIEL DES MOYENS ALLOUES AU CONTRAT DE LIQUIDITE Au titre du contrat de liquidité confié par la société VIRBAC S.A. à la société EXANE BNP PARIBAS, les moyens suivants figuraient au [...]

Affimed Announces Second Quarter 2017 Financial Results and Corporate Update Conference Call

25/07/2017 - 11:00

Heidelberg, Germany, July 25, 2017 - Affimed N.V. (Nasdaq: AFMD) today announced that on August 1, 2017, the Company will release its financial results for the quarter ended June 30, 2017. The Company's management team [...]

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

25/07/2017 - 09:00

FIT Biotech Oy Company release July 25, 2017 at 10:00 AM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]

Sandoz expands partnership with World Child Cancer, to help children access treatment in four developing countries

25/07/2017 - 07:15

Expanded partnership to help "even the odds" of survival for children with cancer in the Philippines, Myanmar, Mexico and Ghana In developed countries, the survival rate for childhood cancer is 80%, while in developing [...]

Novavax Announces Positive Topline Data from Phase 2 Older Adult Trial and Provides Path Forward for RSV F Vaccine Programs

24/07/2017 - 22:05

Phase 2 data in older adults (E205) demonstrate adjuvants and 2-dose regimens significantly increase the magnitude, duration and quality of the RSV F Vaccine immune response New data demonstrate that Novavax' construct [...]

Communiqué : Point sur l'obtention des autorisations des autorités de la concurrence dans le cadre du projet de rapprochement entre Essilor et Luxottica

24/07/2017 - 18:00

Point sur l'obtention des autorisations des autorités de la concurrence dans le cadre du projet de rapprochement entre Essilor et Luxottica Version PDF du communiqué Charenton-le-Pont, France et Milan, Italie (le 24 [...]

News Release: Antitrust process update for the proposed combination between Essilor and Luxottica

24/07/2017 - 18:00

Antitrust process update for the proposed combination between Essilor and Luxottica PDF Version of the news release Charenton-le-Pont, France and Milan, Italy (July 24, 2017) - The proposed combination between Essilor ( [...]

Ossur Hf : Transactions in relation to share buyback program

24/07/2017 - 18:00

Announcement from Össur hf. No. 51/2017 Reykjavík, 24 July 2017 On 1 December 2016, Össur hf. initiated a new share buy-back program, see Company announcement no. 96/2016. The purpose of the share buyback program is to [...]

Oriola Corporation - Repurchase of own shares on 24 July 2017

24/07/2017 - 17:45

ORIOLA CORPORATION STOCK EXCHANGE RELEASE 24 JULY 2017 AT 18:45 EEST In the Nasdaq Helsinki Date 24 July 2017 Exchange transaction Buy Share trading code OKDBV Amount, shares 16.657 Average price/share, EUR 3,5601 Total [...]

Innocoll and Gurnet Point Announcement relating to the Scheme becoming Effective

24/07/2017 - 15:26

NOT FOR RELEAS E, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION FOR IMMEDIATE [...]

Corning and Gerresheimer Collaborate to Deliver New Corning Valor(TM) Glass to the Pharmaceutical Packaging Market

24/07/2017 - 14:30

Remarkable glass innovation enables enhanced quality parenteral packaging CORNING, N.Y. and DUSSELDORF, GERMANY; JULY 24, 2017 - Corning Incorporated (NYSE: GLW) and Gerresheimer AG announce that they are accelerating [...]

Minerva Neurosciences Announces Departure of Directors

24/07/2017 - 14:30

WALTHAM, Mass., July 24, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, [...]

Novo Nordisk A/S - Share repurchase programme

24/07/2017 - 11:35

Bagsværd, Denmark, 24 July 2017 - On 2 February 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]

LIDDS: Clarification regarding signed research agreement

24/07/2017 - 08:55

With reference to press release LIDDS signs research agreement with major European pharma company, published 21 July 2017 at 10:00 CET, we hereby announce that the agreement party is Ferring Pharmaceuticals. Contact [...]